Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation

KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and... REVIEW KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation Markku Miettinen, MD and Jerzy Lasota, MD Key Words: KIT, CD117, gastrointestinal stromal tumor, lymphoma, Abstract: CD117 (KIT) is a type III receptor tyrosine kinase melanoma, seminoma, carcinoma, mutation operating in cell signal transduction in several cell types. Normally (Appl Immunohistochem Mol Morphol 2005;13:205–220) KIT is activated (phosphorylated) by binding of its ligand, the stem cell factor. This leads to a phosphorylation cascade ultimately activating various transcription factors in different cell types. Such activation regulates apoptosis, cell differentiation, proliferation, IT receptor tyrosine kinase was assigned cluster number chemotaxis, and cell adhesion. KIT-dependent cell types include KCD117 during the fifth international conference of mast cells, some hematopoietic stem cells, germ cells, melanocytes, leukocyte typing in Boston in November 1993. KIT is and Cajal cells of the gastrointestinal tract, and neoplasms of these a tyrosine kinase growth factor receptor expressed in diverse cells are examples of KIT-positive tumors. Other KIT-positive normal cell types, including Cajal cells of the gastrointestinal tract, cells include epithelial cells in skin adnexa, breast, and subsets of mast cells and subsets of hematopoietic stem cells, germ cells, cerebellar neurons. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied Immunohistochemistry & Molecular Morphology Wolters Kluwer Health

KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation

Download PDF
16 pages

Loading next page...
 
/lp/wolters-kluwer-health/kit-cd117-colon-a-review-on-expression-in-normal-and-neoplastic-nIW1nPkgTK

References (246)

Copyright
Copyright © 2005 by Lippincott Williams & Wilkins
ISSN
1541-2016
eISSN
1533-4058
DOI
10.1097/01.pai.0000173054.83414.22
Publisher site
See Article on Publisher Site

Abstract

REVIEW KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation Markku Miettinen, MD and Jerzy Lasota, MD Key Words: KIT, CD117, gastrointestinal stromal tumor, lymphoma, Abstract: CD117 (KIT) is a type III receptor tyrosine kinase melanoma, seminoma, carcinoma, mutation operating in cell signal transduction in several cell types. Normally (Appl Immunohistochem Mol Morphol 2005;13:205–220) KIT is activated (phosphorylated) by binding of its ligand, the stem cell factor. This leads to a phosphorylation cascade ultimately activating various transcription factors in different cell types. Such activation regulates apoptosis, cell differentiation, proliferation, IT receptor tyrosine kinase was assigned cluster number chemotaxis, and cell adhesion. KIT-dependent cell types include KCD117 during the fifth international conference of mast cells, some hematopoietic stem cells, germ cells, melanocytes, leukocyte typing in Boston in November 1993. KIT is and Cajal cells of the gastrointestinal tract, and neoplasms of these a tyrosine kinase growth factor receptor expressed in diverse cells are examples of KIT-positive tumors. Other KIT-positive normal cell types, including Cajal cells of the gastrointestinal tract, cells include epithelial cells in skin adnexa, breast, and subsets of mast cells and subsets of hematopoietic stem cells, germ cells, cerebellar neurons.

Journal

Applied Immunohistochemistry & Molecular Morphology – Wolters Kluwer Health

Published: Sep 1, 2005

There are no references for this article.